Inventor
FLENTGE CHARLES A
US42 patents
⚠️ This page may combine multiple inventors who share the name “FLENTGE CHARLES A”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
ABBOTT LAB
12 patentsUS5101015AMar 31, 1992
Reagents for an amphetamine-class fluorescence polarization immunoassay
ABBOTT LAB53 citations94
US5354693AOct 11, 1994
Reagents, methods and kits for an amphetamine-class fluorescence polarization immunoassy
ABBOTT LAB43 citations90
US7517876B2Apr 14, 2009
Anti-infective agents
ABBOTT LAB13 citations83
US7378414B2May 27, 2008
Anti-infective agents
ABBOTT LAB17 citations82
US5248791ASep 28, 1993
Reagents, methods and kits for an amphetamine-class fluorescence polarization immunoassay
ABBOTT LAB14 citations71
US4559173ADec 17, 1985
N-substituted dibenz[b,f]azepine salts
ABBOTT LAB3 citations63
US4543412ASep 24, 1985
Phenobarbital enzyme inhibitors
ABBOTT LAB3 citations62
US7786153B2Aug 31, 2010
Compounds that are useful for improving pharmacokinetics
ABBOTT LAB2 citations61
US4451652AMay 29, 1984
Substituted theophylline salts
ABBOTT LAB3 citations61
US7834043B2Nov 16, 2010
HIV protease inhibiting compounds
ABBOTT LAB1 citations51
US7696226B2Apr 13, 2010
HIV protease inhibiting compounds
ABBOTT LAB1 citations51
US7538105B2May 26, 2009
Anti-infective agents
ABBOTT LAB0 citations50
KNOPP BIOSCIENCES LLC
10 patentsUS9914708B2Mar 13, 2018
Benzoimidazol-1,2-yl amides as Kv7 channel activators
KNOPP BIOSCIENCES LLC10 citations92
US9481653B2Nov 1, 2016
Benzoimidazol-1,2-yl amides as Kv7 channel activators
KNOPP BIOSCIENCES LLC15 citations92
US11724990B2Aug 15, 2023
Kv7 channel activators compositions and methods of use
KNOPP BIOSCIENCES LLC4 citations85
US10851067B2Dec 1, 2020
Kv7 channel activators compositions and methods of use
KNOPP BIOSCIENCES LLC6 citations83
US10385025B2Aug 20, 2019
Benzoimidazol-1,2-yl amides as Kv7 channel activators
KNOPP BIOSCIENCES LLC9 citations83
US10106536B2Oct 23, 2018
Imidazo(4,5-B) pyridin-2-yl amides as KV7 channel activators
KNOPP BIOSCIENCES LLC5 citations83
US9650376B2May 16, 2017
Imidazo(4,5-B) pyridin-2-yl amides as KV7 channel activators
KNOPP BIOSCIENCES LLC8 citations81
US11261162B2Mar 1, 2022
KV7 channel activators compositions and methods of use
KNOPP BIOSCIENCES LLC3 citations72
US10906877B2Feb 2, 2021
Benzoimidazol-1,2-yl amides as Kv7 channel activators
KNOPP BIOSCIENCES LLC1 citations72
US10526328B2Jan 7, 2020
Imidazo[4,5-b]pyridin-2-yl amides as Kv7 channel activators
KNOPP BIOSCIENCES LLC0 citations51
ABBVIE INC
8 patentsUS9006387B2Apr 14, 2015
Anti-viral compounds
ABBVIE INC4 citations72
US9139536B2Sep 22, 2015
Anti-infective agents and uses thereof
ABBVIE INC2 citations62
US9637478B2May 2, 2017
Antiviral compounds and uses thereof
ABBVIE INC0 citations52
US9353091B2May 31, 2016
Antiviral compounds and uses thereof
ABBVIE INC0 citations52
US10039754B2Aug 7, 2018
Anti-viral compounds
ABBVIE INC0 citations51
US10028937B2Jul 24, 2018
Anti-viral compounds
ABBVIE INC0 citations51
US9586978B2Mar 7, 2017
Anti-viral compounds
ABBVIE INC0 citations51
US8741938B2Jun 3, 2014
Compounds that are useful for improving pharmacokinetics
ABBVIE INC0 citations50
DEGOEY DAVID A
3 patentsFLENTGE CHARLES A
3 patentsBIOHAVEN THERAPEUTICS LTD
3 patentsUS12351559B2Jul 8, 2025
Benzoimidazol benzomidazol-1,2-yl amides as Kv7 channel activators
BIOHAVEN THERAPEUTICS LTD0 citations62
US12286408B2Apr 29, 2025
KV7 channel activators compositions and methods of use
BIOHAVEN THERAPEUTICS LTD0 citations62
US11834418B2Dec 5, 2023
Benzoimidazol-1,2-yl amides as Kv7 channel activators
BIOHAVEN THERAPEUTICS LTD0 citations62